Double hit: Evans syndrome after malignant thymoma treatment and parvovirus b19 infection

John Xie, Gerard Chaaya, Rachna Jetly-Shridhar, Thomas Stewart Atkinson

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Malignancies are often associated with autoimmune diseases, which are addressed by treating the underlying cancer. However, there are rare malignancies that can cause autoimmune diseases even after appropriate treatment. Our patient is a 39-year-old Hispanic man with a malignant thymoma recently treated with chemotherapy and radiation who presented with syncope and dyspnoea. He was found to be both anaemic and thrombocytopenic. His labs were consistent with autoimmune haemolytic anaemia (AIHA), except his reticulocyte count was unexpectedly low. Bone marrow biopsy supported a diagnosis of Evans syndrome, a rare autoimmune condition characterised by (AIHA) combined with immune thrombocytopenia. He was also found to have an acute parvovirus B19 infection. He was treated with steroids and RBC transfusion. His blood counts gradually returned to baseline, with improvement in symptoms. This patient's thymoma treatment and active parvovirus B19 infection likely both played a role in the development of Evans syndrome.

Original languageEnglish (US)
Article numbere233485
JournalBMJ Case Reports
Volume13
Issue number3
DOIs
StatePublished - Mar 18 2020

Keywords

  • haematology (incl blood transfusion)
  • oncology

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Double hit: Evans syndrome after malignant thymoma treatment and parvovirus b19 infection'. Together they form a unique fingerprint.

Cite this